Research

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2025.

For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis.

A new paper published in Nature Reviews Neurology offers a cogent overview of patient involvement in medicine in the context of public participation in democratic processes.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024.

Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.

EBRAINS has announced an open call for proposals aimed at integrating models of the brain's vascular architecture with EBRAIN’s Human Brain Atlas, with the aim of enhancing the usability of brain vasculature data for research and clinical applications, fostering collaboration between institutions and the EBRAINS consortium.

Our Paper of the Month for October is a phase 2, double-blind, randomised, placebo-controlled trial investigating the efficacy of a monoclonal antibody (Lu AG09222) that inhibits PACAP signalling.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2024.

Our paper of the month for September updates the 2020 Lancet Commission report on the identification of risk factors for dementia, adding two more risk factors to the list.